DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CEFPROZIL

« Back to Dashboard

Clinical Trials for Cefprozil

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00778245	Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions	Completed	Ranbaxy Laboratories Limited	N/A	The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions.
NCT00778557	Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions	Completed	Ranbaxy Laboratories Limited	N/A	The study was conducted as a blinded, randomized, 3-way crossover study to compare the single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fasting conditions
NCT00778739	Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions	Completed	Ranbaxy Laboratories Limited	N/A	The study was conducted as an open-label, randomized, 2-way crossover study to compare the single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fed conditions
NCT00778778	Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions	Completed	Ranbaxy Laboratories Limited	N/A	The objective of this study was to assess the single-dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fasting conditions.
NCT00835354	Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting	Completed	Teva Pharmaceuticals USA	Phase 1	The objective of this study is to compare the relative bioavailability of cefprozil for oral suspension 250 mg/5 mL (TEVA Pharmaceuticals USA) with that of CEFZIL® for Oral Suspension 250 mg/5 mL (Bristol-Myers Squibb) in healthy, non-smoking adults under non-fasting conditions.

Clinical Trial Conditions for Cefprozil

Condition Name

Condition Name for Cefprozil
Intervention	Trials
Healthy	12
Osteomyelitis	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cefprozil
Intervention	Trials
Osteomyelitis	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cefprozil

Trials by Country

Trials by Country for Cefprozil
Location	Trials
United States	7
Canada	4

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cefprozil
Location	Trials
Missouri	4
Texas	2
Kentucky	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cefprozil

Clinical Trial Phase

Clinical Trial Phase for Cefprozil
Clinical Trial Phase	Trials
Phase 1	8
Phase 0	1
N/A	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cefprozil
Clinical Trial Phase	Trials
Completed	12
Not yet recruiting	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cefprozil

Sponsor Name

Sponsor Name for Cefprozil
Sponsor	Trials
Sandoz	4
Teva Pharmaceuticals USA	4
Ranbaxy Laboratories Limited	4

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cefprozil
Sponsor	Trials
Industry	12
Other	3

Export unavailable in trial.
Subscribe for complete access.